Compounds and methods for treating cancer
USRE50319E1 · kind E1 · reissue
0Cited by
21References
70Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 10, 2022 |
| Grant date | Mar 4, 2025 |
| Priority date | — |
| Expiry date | Nov 10, 2042 |
Classification
- Technology area (CPC —)General
Abstract
The present application provides, in some aspects, methods of treating cancers, such as homologous recombination (HR)-deficient cancers. In some embodiments, the disclosure provides a method for treating cancer by administering to a subject a compound of Formula (I):(I), or a pharmaceutically acceptable salt thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.